Zheng, X., Liu, H., Shi, L., Zeng, Z., Zhang, X., Luo, S., Cai, Y., Li, Z., Liu, Z., Hou, Y., Yang, Z., He, X., Ke, J., Huang, L., Luo, Y., Kang, L. (2026). Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial. Nature Communications. https://doi.org/10.1038/s41467-025-65162-8